Rare diseases
Investigational molecules
Locations
Back to France1 185 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients
FranceStudy on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients
FranceFranceStudy on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation
FranceStudy Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
FranceStudy of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy
FranceStudy on Early Detection of Triple-Negative Breast Cancer Relapse Using 68Ga-FAPI-46 for Patients at High Risk
FranceStudy on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy
FranceStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
FranceStudy on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer
FranceContinued Cancer Treatment Study with Abiraterone, Ipatasertib, Tiragolumab, and Drug Combination for Patients from Previous Genentech/Roche Trials
FranceStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
